Page last updated: 2024-11-04

vorinostat and Keratitis

vorinostat has been researched along with Keratitis in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Keratitis: Inflammation of the cornea.

Research Excerpts

ExcerptRelevanceReference
"Fungal keratitis is one of the leading causes of blindness of infected corneal diseases, but the pathogenesis of fungal keratitis is not fully understood and therefore the treatment of the disease by medication is still under investigation."1.51Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice. ( Han, L; He, S; Li, X; Liu, X; Sun, S; Yin, R; Yuan, M; Zhang, Y, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, X1
Yuan, M1
Yin, R1
Liu, X1
Zhang, Y1
Sun, S1
Han, L1
He, S1

Other Studies

1 other study available for vorinostat and Keratitis

ArticleYear
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice.
    Scientific reports, 2019, 07-08, Volume: 9, Issue:1

    Topics: Acetylation; Adult; Aged; Animals; Cytokines; Dimethyl Sulfoxide; Disease Models, Animal; Eye Infect

2019